Fig. 1From: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapyKaplan-Meier curves comparing (a) the molGPA score with (b) the VTS score including cumulative brain metastases volume, timing of metastases, cumulative brain metastases volume and concomitant systemic treatmentBack to article page